Mudanpi is a key specific component in DZXY, and its active ingredient, paeonol (PAE), has been proven to promote the Th17/Treg balance in AIT rats by inhibiting the HMGB1/RAGE pathway, thereby protecting against pathological damage in autoimmune thyroid rats (Zhang et al., 2025). Here, HMGB1 is linked to autoimmune thyroid disease.